Immunocept Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Immunocept General Information

Description

Developer of a medical device designed for blood filtration therapy. The company's device helps to modulate the immune system's heightened call-to-action by removing inflammatory mediators through a controlled filtration process, enabling physicians to treat sepsis and other diseases of destructive inflammation.

Contact Information

Website
www.immunocept.com
Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 1800 Lawrence Street
  • Denver, CO 80202
  • United States
+1 (972)
Primary Industry
Therapeutic Devices
Acquirer
SeaStar Medical
Corporate Office
  • 1800 Lawrence Street
  • Denver, CO 80202
  • United States
+1 (972)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunocept Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 12-Jul-2018 Completed Startup
2. Angel (individual) 02-Aug-2017 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Immunocept’s complete valuation and funding history, request access »

Immunocept Patents

  • 29

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • Pending

  • Expiring in next 12 mo

Immunocept Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2003228309-A1 Method and system for colloid exchange therapy Inactive 13-Mar-2003
EP-1608417-A1 Method and system for colloid exchange therapy Inactive 13-Mar-2003
EP-1608417-A4 Method and system for colloid exchange therapy Inactive 13-Mar-2003
AU-2002319690-A1 Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease Inactive 25-Jul-2001
EP-1409041-A2 Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease Inactive 25-Jul-2001 A61M1/3472
To view Immunocept’s complete patent history, request access »

Immunocept Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innosphere Ventures Accelerator/Incubator
To view Immunocept’s complete investors history, request access »

Ready to get started?

Request a free trial

Immunocept FAQs

  • When was Immunocept founded?

    Immunocept was founded in 1999.

  • Where is Immunocept headquartered?

    Immunocept is headquartered in Denver, CO.

  • What industry is Immunocept in?

    Immunocept’s primary industry is Therapeutic Devices.

  • Is Immunocept a private or public company?

    Immunocept is a Private company.

  • What is Immunocept’s current revenue?

    The current revenue for Immunocept is .

  • How much funding has Immunocept raised over time?

    Immunocept has raised $530K.

  • Who are Immunocept’s investors?

    Innosphere Ventures has invested in Immunocept.

  • When was Immunocept acquired?

    Immunocept was acquired on 12-Jul-2018.

  • Who acquired Immunocept?

    Immunocept was acquired by SeaStar Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »